patient selection for autosct in hl & increasing cr rate before autosct with novel salvage regimens
Published 1 year ago • 18 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
2:17
the impact of checkpoint inhibitor-based salvage regimens in patients with r/r hl undergoing autosct
-
1:06
autosct for elderly patients with multiple myeloma in their last quarter of life
-
1:28
the role of autosct in hodgkin lymphoma
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
2:00
the effectiveness of ambulatory care for patients undergoing stem cell transplantation
-
2:26
lenalidomide as post-autosct maintenance therapy for multiple myeloma
-
1:36
education initiatives for car t-cell therapy
-
2:09
heart transplantation in attr amyloidosis
-
1:12
managing gvhd in patients undergoing sct
-
1:52
perspectives on patient selection for car-t therapy
-
1:13
efficacy of transplantation in hl
-
1:52
evaluating surrogacy endpoints in cll clinical trials
-
2:29
the safety and feasibility of car-t & bispecifics in patients with myeloma after prior allosct
-
0:59
identifying molecular markers for the prediction of icaht in patients receiving car t-cell therapy
-
0:32
enhancing outcomes of patients with dlbcl treated with car t-cell therapy
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
2:39
the patient registry for monitoring long term safety of novel therapies
-
4:04
management of al amyloidosis: measurement modalities, transplantation & car-t